Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biofrontera (BFRIW) Non Operating Income (2020 - 2025)

Historic Non Operating Income for Biofrontera (BFRIW) over the last 6 years, with Q3 2025 value amounting to -$365000.0.

  • Biofrontera's Non Operating Income rose 4830.03% to -$365000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $27000.0, marking a year-over-year decrease of 9958.74%. This contributed to the annual value of -$527000.0 for FY2024, which is 12058.59% down from last year.
  • As of Q3 2025, Biofrontera's Non Operating Income stood at -$365000.0, which was up 4830.03% from -$264000.0 recorded in Q2 2025.
  • In the past 5 years, Biofrontera's Non Operating Income ranged from a high of $8.7 million in Q1 2022 and a low of -$12.9 million during Q4 2021
  • For the 5-year period, Biofrontera's Non Operating Income averaged around $377736.8, with its median value being $79000.0 (2021).
  • As far as peak fluctuations go, Biofrontera's Non Operating Income surged by 1091392.41% in 2022, and later tumbled by 26024.21% in 2023.
  • Quarter analysis of 5 years shows Biofrontera's Non Operating Income stood at -$12.9 million in 2021, then surged by 122.03% to $2.8 million in 2022, then skyrocketed by 160.4% to $7.4 million in 2023, then crashed by 95.76% to $313000.0 in 2024, then tumbled by 216.61% to -$365000.0 in 2025.
  • Its Non Operating Income was -$365000.0 in Q3 2025, compared to -$264000.0 in Q2 2025 and $343000.0 in Q1 2025.